Study of L-Glutamic Acid in Solid State for its Possible Use as a Gamma Dosimeter at Different Temperatures (77, 195 and 295 K)

The experimental response of the dosimeter as a function of the irradiation temperature plays an important role, and this effect has consequences in the practical applications of dosimetry. In this work, L-glutamic acid (2-aminopentanedioic acid) is proposed to be a good response, easy to handle, and a cheap gamma dosimeter. For this purpose, polycrystalline samples were irradiated with gamma rays at 77, 195, and 295 K and doses in the kiloGray range (43–230 kGy). The potential use of the glutamic acid system as a chemical dosimeter is based on the formation of stable free radicals when the amino acid is exposed to ionizing radiation. The observed species in these experiments were attributed to deamination and decarboxylation reactions that were studied using electron spin resonance (ESR). The results indicate that the analysis generates a linear response as the irradiation dose increases in a reliable range for industrial and research purposes at three different temperatures

Gamma Dosimetry Using Some Dyes in Organic Solvents Solutions at 295 and 77 K

The aim of this work is to study the behavior under irradiation of different dyes (green malachite, methyl orange, red cresol, and bromothymol blue) in organic solvents (acetone and methanol) at different gamma doses and different temperatures to propose them as possible dosimeters for low-temperature applications. For this purpose, organic dissolutions were irradiated with gamma rays in the kiloGray (kGy) range at 77 and 295 K, and the color bleaching of the solutions was followed spectrophotometrically (UV-Vis range). The response curves at different temperatures show the linear range interval from 10 to 40 kGy with correlation coefficients of 0.999 and 0.998 for some systems. This is the main reason to continue carrying out studies that allow the proposal of these systems as chemical dosimeters

Predictors of enhancing human physical attractiveness: Data from 93 countries

People across the world and throughout history have gone to great lengths to enhance their physical appearance. Evolutionary psychologists and ethologists have largely attempted to explain this phenomenon via mating preferences and strategies. Here, we test one of the most popular evolutionary hypotheses for beauty-enhancing behaviors, drawn from mating market and parasite stress perspectives, in a large cross-cultural sample. We also test hypotheses drawn from other influential and non-mutually exclusive theoretical frameworks, from biosocial role theory to a cultural media perspective. Survey data from 93,158 human participants across 93 countries provide evidence that behaviors such as applying makeup or using other cosmetics, hair grooming, clothing style, caring for body hygiene, and exercising or following a specific diet for the specific purpose of improving ones physical attractiveness, are universal. Indeed, 99% of participants reported spending >10 min a day performing beauty-enhancing behaviors. The results largely support evolutionary hypotheses: more time was spent enhancing beauty by women (almost 4 h a day, on average) than by men (3.6 h a day), by the youngest participants (and contrary to predictions, also the oldest), by those with a relatively more severe history of infectious diseases, and by participants currently dating compared to those in established relationships. The strongest predictor of attractiveness-enhancing behaviors was social media usage. Other predictors, in order of effect size, included adhering to traditional gender roles, residing in countries with less gender equality, considering oneself as highly attractive or, conversely, highly unattractive, TV watching time, higher socioeconomic status, right-wing political beliefs, a lower level of education, and personal individualistic attitudes. This study provides novel insight into universal beauty-enhancing behaviors by unifying evolutionary theory with several other complementary perspectives

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Diseño e implementación de un analizador de perturbaciones eléctricas

En este trabajo se desarrolla un propósito de laboratorio de un analizador de perturbaciones eléctricas, que cumpla con las características de un instrumento virtual (VI) basado en tecnología de computadoras AT/XT y utilizando una tarjeta de adquisición de datos (DAQ)PCL718. El software es una aplicación en el ambiente windows desarrollado en el lenguaje de programación visual C++, el cual permite crear programas con una interfaz computadora-usuario amigable. Este analizador de perturbaciones junto a una base de datos permite dar un diagnóstico de calidad del sistema de distribución por medio de reportes en formato de texto y gráfico, la información contenida en estos reportes es el resultado de recabar un cumulo de muestras del sistema de distribución, estos reportes pueden ser entregados al abonado para que tenga un parámetro de referencia del estado de su suministro de energía eléctric

Cut and carry vs. grazing of cultivated pastures in small-scale dairy systems in the central highlands of Mexico

Small-scale dairy systems are an option to alleviate poverty and contribute up to 37% of milk production in Mexico; however high costs affect their economic sustainability. Since grazing may reduce feeding costs, a participatory on farm experiment was undertaken to compare animal performance and feeding costs of the traditional cut-and-carry strategy or grazing cultivated pastures, during the dry season in the highlands of Mexico. Pastures of perennial and annual ryegrasses with white clover were utilised, complemented with maize silage and commercial concentrate. Five dairy cows were assigned to each strategy. The experiment ran for 12 weeks, recording weekly milk yields and fat and milk protein content; live-weight and body condition score every 14 days. Analysis was as a split-plot design. The adjusted (covariance) mean milk yield was 18.78 kg/cow/day with no significant differences (P>0.05) between treatments, and no significant differences for live-weight or body condition score. There were no significant differences for milk fat (P>0.05), but there were for protein in milk (